Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma

Yassine Al Tabaa (1) , Emmanuelle Tchernonog (2, 1) , Pierre Faurie , Anne Ségolène Cottereau (3) , Hélène Monjanel (3) , Antoine Bonnet , Steven Le Gouill (4) , Emmanuel Gyan , Hervé Ghesquières , Denis Mariano-Goulart (5, 6) , Guillaume Cartron (1, 2)

1 CHU Montpellier
2 DIMNP - Dynamique des interactions membranaires normales et pathologiques
3 CHU Tenon [AP-HP]
4 CRCINA-ÉQUIPE 10 - Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma
5 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
6 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]

Mots clés: Post-treatment evaluation; 18-FDG-PET/CT; Plasmablastic lymphoma; FDG avidity

Domaines: Imagerie; Médecine nucléaire; Médecine humaine et pathologie

Yassine Al Tabaa, Emmanuelle Tchernonog, Pierre Faurie, Anne Ségolène Cottereau, Hélène Monjanel, et al.. Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 (10), pp.1705-1709. ⟨10.1007/s00259-018-4020-5⟩. ⟨hal-02340143⟩